Tumour prevention by a single antibody domain targeting the interaction of signal transduction proteins with RAS.
Many disease-related processes occur via protein complexes that are considered undruggable with small molecules. An example is RAS, which is frequently mutated in cancer and contributes to initiation and maintenance of the disease by constitutive signal transduction through protein interaction with...
Main Authors: | Tanaka, T, Williams, R, Rabbitts, T |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2007
|
Similar Items
-
Interfering with RAS-effector protein interactions prevent RAS-dependent tumour initiation and causes stop-start control of cancer growth.
by: Tanaka, T, et al.
Published: (2010) -
Single Domain Antibody Fragments as Drug Surrogates Targeting Protein–Protein Interactions inside Cells
by: Terence H. Rabbitts, et al.
Published: (2013-05-01) -
Intracellular antibody capture (IAC) methods for single domain antibodies.
by: Tanaka, T, et al.
Published: (2012) -
Selection of complementary single-variable domains for building monoclonal antibodies to native proteins.
by: Tanaka, T, et al.
Published: (2009) -
Protocol for the selection of single-domain antibody fragments by third generation intracellular antibody capture.
by: Tanaka, T, et al.
Published: (2010)